CAR-T cell therapy is a leading immunotherapy treatment primarily used to treat blood cancers. Recent studies have focused on enhancing CAR therapy by improving T-cell persistence. Learn more about this here.
After an allogeneic stem cell transplant, many patients suffer from an associated disease called graft-versus-Host disease. Patients with blood cancer face a serious risk from this disease, and its important that we develop new therapies to treat it.
.png)
